Scalable Sleep Apnoea Endotype Profiling and Estimated Oral Appliance Treatment Response in a Large Clinical Cohort
Respirology · 13.11.2026
DOI: 10.1002/resp.70338 ↗Kurz gefasst
Fachartikel in der Zeitschrift Respirology, online erschienen am 13.11.2026. Verfasst von Jack Manners und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Adelaide Institute for Sleep Health/Flinders Health and Medical Research Institute: Sleep Health, Flinders University, Adelaide, South Australia,…. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council (NHMRC) of Australia Leadership Fellowship, National Health and Medical Research Council.
Abstract (Originalsprache)
Background and Objective Obstructive sleep apnoea (OSA) pathogenesis is heterogeneous with important contributions from impaired upper airway anatomy and at least three key non‐anatomical endotypes. Detailed physiology assessments in a relatively small number of well‐characterized participants indicate wide interindividual variability in pharyngeal collapsibility and that ~70% have impairment in one or more non‐anatomical endotype. In this study, we applied recently developed models that use standard clinical and polysomnography data to estimate OSA endotypes and oral appliance therapy response in a large clinical population.
Methods
OSA endotypes and oral appliance therapy responses were estimated using standard sleep study outputs and clinical data (age and BMI) from > 6500 consecutive home‐based diagnostic studies with an Apnoea/Hypopnea Index (AHI) > 5 events/h (Sleep Profiler PSG‐Advanced Brain Monitoring). The proportion of participants who were estimated to have impairment in one or more OSA endotypes was calculated according to previously published physiological cutoffs.
Results
On average, participants (39% female) had moderately severe OSA (AHI = 28 ± 23 events/h [Mean ± SD]), were middle aged (49 ± 16 years) and obese (BMI = 31 ± 7 kg/m 2 ). 29% were estimated to have only mild anatomical compromise. 23% had poor dilator muscles, 31% high loop gain and 29% had a low arousal threshold. 62% had severe (“bad”) impairment in one or more non‐anatomical endotypes. ~60% were predicted to respond to oral appliance therapy.
Conclusions
These novel data highlight the heterogeneity of OSA in a large clinical OSA patient population and the feasibility for endotype‐informed precision medicine for OSA via application of novel physiology‐based algorithms using home sleep study recordings at scale.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Adelaide Institute for Sleep Health/Flinders Health and Medical Research Institute: Sleep Health, Flinders University, Adelaide, South Australia, Australia.
- CSIRO DATA61, Hobart, Australia.
- Advanced Brain Monitoring, Carlsbad, California, USA.
ORCID-Profile: Jack Manners, Daniel J Levendowski, Danny J Eckert
Förderung
- National Health and Medical Research Council (NHMRC) of Australia Leadership Fellowship
- National Health and Medical Research Council
Zitieren
APA
Manners, J., Dutta, R., Levendowski, D. J., & Eckert, D. J. (2026). Scalable Sleep Apnoea Endotype Profiling and Estimated Oral Appliance Treatment Response in a Large Clinical Cohort. Respirology. https://doi.org/10.1002/resp.70338
Vancouver
Manners J, Dutta R, Levendowski DJ, Eckert DJ. Scalable Sleep Apnoea Endotype Profiling and Estimated Oral Appliance Treatment Response in a Large Clinical Cohort. Respirology. 2026. doi:10.1002/resp.70338
BibTeX
@article{Manners2026,
author = {Manners, Jack and Dutta, Ritaban and Levendowski, Daniel J and Eckert, Danny J},
title = {Scalable Sleep Apnoea Endotype Profiling and Estimated Oral Appliance Treatment Response in a Large Clinical Cohort},
journal = {Respirology},
year = {2026},
doi = {10.1002/resp.70338}
}
EUVIMED